Comparison of the Cancer Gene Targeting and Biochemical Selectivities of All Targeted Kinase Inhibitors Approved for Clinical Use

The anti-proliferative activities of all twenty-five targeted kinase inhibitor drugs that are in clinical use were measured in two large assay panels: (1) a panel of proliferation assays of forty-four human cancer cell lines from diverse tumour tissue origins; and (2) a panel of more than 300 kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Uitdehaag, Joost C. M., de Roos, Jeroen A. D. M., van Doornmalen, Antoon M., Prinsen, Martine B. W., de Man, Jos, Tanizawa, Yoshinori, Kawase, Yusuke, Yoshino, Kohichiro, Buijsman, Rogier C., Zaman, Guido J. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961306/
https://www.ncbi.nlm.nih.gov/pubmed/24651269
http://dx.doi.org/10.1371/journal.pone.0092146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961306/
https://www.ncbi.nlm.nih.gov/pubmed/24651269
http://dx.doi.org/10.1371/journal.pone.0092146

Ejemplares similares